CONFERENCES

      Research in Computational Molecular Biology Conference Series

      Research in Computational Molecular Biology (RECOMB) conferences aim at attracting research contributions in all areas of computational molecular biology. Starting with emphazis on mathematical and computational side of the field, currect focus remains on computational advances and effective applications of computational techniques to achieve biological innovation. In addition to main annual event, RECOMB Satellite Conference Series consist of focused meetings covering various specialized aspects of bioinformatics.

      RECOMB Satellite Meeting 2011

      Date

      Oct 14, 2011 - Oct 19, 2011

      Location

      Vancouver, Canada

      The 8th Annual RECOMB Satellite on Regulatory Genomics is held jointly with the 6th Annual DREAM on Reverse Engineering Challenges, the 7th Annual RECOMB Satellite on Systems Biology.

      See related posters

      RECOMB 2010

      Date

      Aug 12, 2010 - Aug 15, 2010

      Location

      Lisbon, Portugal

      This is the 14th Annual International Conference.

      See related posters

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.